These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
734 related articles for article (PubMed ID: 26266776)
1. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis. Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776 [TBL] [Abstract][Full Text] [Related]
2. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis. Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926 [TBL] [Abstract][Full Text] [Related]
3. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Deegens JK; Dijkman HB; Borm GF; Steenbergen EJ; van den Berg JG; Weening JJ; Wetzels JF Kidney Int; 2008 Dec; 74(12):1568-76. PubMed ID: 18813290 [TBL] [Abstract][Full Text] [Related]
4. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease. da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279 [TBL] [Abstract][Full Text] [Related]
5. Ultrastructural Characterization of Proteinuric Patients Predicts Clinical Outcomes. Royal V; Zee J; Liu Q; Avila-Casado C; Smith AR; Liu G; Mariani LH; Hewitt S; Holzman LB; Gillespie BW; Hodgin JB; Barisoni L J Am Soc Nephrol; 2020 Apr; 31(4):841-854. PubMed ID: 32086276 [TBL] [Abstract][Full Text] [Related]
6. Epithelial cell foot process effacement in podocytes in focal and segmental glomerulosclerosis: a quantitative analysis. Kfoury H Ultrastruct Pathol; 2014 Oct; 38(5):303-8. PubMed ID: 24956069 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic significance of glomerular epithelial cell vacuolization and podocyte effacement in children with minimal lesion nephrotic syndrome and focal segmental glomerulosclerosis: an ultrastructural study. Chiang ML; Hawkins EP; Berry PL; Barrish J; Hill LL Clin Nephrol; 1988 Jul; 30(1):8-14. PubMed ID: 3061695 [TBL] [Abstract][Full Text] [Related]
8. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats. Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165 [TBL] [Abstract][Full Text] [Related]
9. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy. Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837 [TBL] [Abstract][Full Text] [Related]
10. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. van den Berg JG; van den Bergh Weerman MA; Assmann KJ; Weening JJ; Florquin S Kidney Int; 2004 Nov; 66(5):1901-6. PubMed ID: 15496161 [TBL] [Abstract][Full Text] [Related]
11. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression. Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525 [TBL] [Abstract][Full Text] [Related]
12. Two different pathways of glomerular enlargement in adults with focal and segmental glomerulosclerosis: a morphometric study. Matsumae T; Fukuzaki M; Takebayashi S; Naito S Am J Nephrol; 1998; 18(1):21-7. PubMed ID: 9481435 [TBL] [Abstract][Full Text] [Related]
13. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies. Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605 [TBL] [Abstract][Full Text] [Related]
15. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)]. Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117 [TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Cho MH; Hong EH; Lee TH; Ko CW Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521 [TBL] [Abstract][Full Text] [Related]
17. Histomorphological classification of focal segmental glomerulosclerosis: a critical evaluation of clinical, histologic and morphometric features. Das P; Sharma A; Gupta R; Agarwal SK; Bagga A; Dinda AK Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):1008-16. PubMed ID: 22982914 [TBL] [Abstract][Full Text] [Related]
18. Ultrastructural changes of podocyte foot processes during the remission phase of minimal change disease of human kidney. Liu XJ; Zhang YM; Wang SX; Liu G Nephrology (Carlton); 2014 Jul; 19(7):392-7. PubMed ID: 24690133 [TBL] [Abstract][Full Text] [Related]